KFDA denies PPA related prescription

Published: 2006-09-20 07:00:00

Updated: 2006-09-20 07:00:00

The Korea Food and Drug Administration (KFDA) squelched a report by a lawmaker that 84 hospitals and clinics nationwide have still prescribed phenylpropanolamine (PPA), an ingredient that may cause hemorrhagic strokes, to their patients for common conditions such as cold, coughs and sore throats.

The controversial issue came after Rep. Chung Hwa-won of the Grand National Party said on Septem...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.